Effects of cisplatin on mitochondrial function and autophagy-related proteins in skeletal muscle of rats

키워드

참고문헌 (40)

1. Frezza M, "Novel metals and metal complexes as platforms for cancer therapy", Curr Pharm Des, 16, pp.1813~1825 (2010)
2. Kelland L, "The resurgence of platinum-based cancer chemotherapy", Nat Rev Cancer, 7, pp.573~584 (2007)
3. 정의택, "Overcoming Multidrug Resistance by Activating Unfolded Protein Response of the Endoplasmic Reticulum in Cisplatin-Resistant A2780", CisR Ovarian Cancer Cells, 2020, pp.53(2), 88~93[DOI]
4. Sakai H, "Mechanisms of cisplatin-induced muscle atrophy", Toxicol Appl Pharmacol, 278, pp.190~199 (2014)
5. 진유진, "Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT", BMB Reports, 52(12), pp.706~711 (2019), 생화학분자생물학회
6. Conte E, "Cisplatin-induced skeletal muscle dysfunction : mechanisms and counteracting therapeutic strategies", Int J Mol Sci, 21, pp.1242~ (2020)
7. Fearon K, "Definition and classification of cancer cachexia : an international consensus", Lancet Oncol, 12, pp.489~495 (2011)
8. Conte E, "Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatininduced cachexia", J Cachexia Sarcopenia Muscle, 8, pp.386~404 (2017)
9. Bresciani E, "JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia", Endocrine, 58, pp.106~114 (2017)
10. Sakai H, "Mechanisms of cisplatin-induced muscle atrophy", Toxicol Appl Pharmacol, 278, pp.190~199 (2014)
11. Dickey DT, "Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models", Cancer Chemother Pharmacol, 62, pp.235~241 (2008)
12. Garcia JM, "Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia", Endocrinology, 149, pp.455~460 (2008)
13. Park SE, "Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer", Sci Rep, 10, pp.17683~ (2020)
14. Lin JF, "Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells", Drug Des Devel Ther, 11, pp.1517~1533 (2017)
15. Cocetta V, "Mitochondrial involvement in cisplatin resistance", Int J Mol Sci, 20, pp.3384~ (2019)
16. Lomeli N, "Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats", Free Radic Biol Med, 102, pp.274~286 (2017)
17. Inapurapu SP, "Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae", Iran J Basic Med Sci, 20, pp.83~89 (2017)
18. Sartori R, "Mechanisms of muscle atrophy and hypertrophy : implications in health and disease", Nat Commun, 12, pp.330~ (2021)
19. Romanello V, "Mitochondrial quality control and muscle mass maintenance", Front Physiol, 6, pp.422~ (2015)
20. Sirago G, "Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia", Sci Rep, 7, pp.1~14 (2017)
21. Hood DA, "Maintenance of skeletal muscle mitochondria in health, exercise, and aging", Annu Rev Physiol, 81, pp.19~41 (2019)
22. Poillet Perez L, "Autophagy is a major metabolic regulator involved in cancer therapy resistance", Cell Rep, 36, pp.109528~ (2021)
23. Paolini A, "Attenuation of autophagy impacts on muscle fibre development, starvation induced stress and fibre regeneration following acute injury", Sci Rep, 8, pp.9062~ (2018)
24. Gąsiorkiewicz BM, "Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer", Invest New Drugs, 39, pp.538~563 (2021)
25. Dikic I, "Mechanism and medical implications of mammalian autophagy", Nat Rev Mol Cell Biol, 19, pp.349~364 (2018)
26. Yu L, "Autophagy pathway : Cellular and molecular mechanisms", Autophagy, 14, pp.207~215 (2018)
27. Metaxakis A, "Autophagy in age-associated neurodegeneration", Cells, 7, pp.37~ (2018)
28. Banerjee A, "Mechanisms for maintaining muscle", Curr Opin Support Palliat Care, 6, pp.451~456 (2012)
29. Youle RJ, "Mitochondrial fission, fusion, and stress", Science, 337, pp.1062~1065 (2012)
30. Kleih M, "Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells", Cell Death Dis, 10, pp.851~ (2019)
31. Gordon JA, "Mitochondrial alterations in cisplatin-induced acute renal failure", Am J Physiol, 250, pp.F991~F998 (1986)
32. Choi YM, "Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation", PLoS One, 10, pp.e0135083~ (2015)
33. Kruspig B, "Targeting succinate : ubiquinone reductase potentiates the efficacy of anticancer therapy", Biochim Biophys Acta, 1863, pp.2065~2071 (2016)
34. Chen J, "Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells", Mol Med Rep, 17, pp.6859~6865 (2018)
35. Fanzani A, "Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems", Toxicol Appl Pharmacol, 250, pp.312~321 (2011)
36. Sandri M, "Autophagy in skeletal muscle", FEBS Lett, 584, pp.1411~1416 (2010)
37. Sandri M, "Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy", Cell, 117, pp.399~412 (2004)
38. Rambold AS, "Mechanisms of mitochondria and autophagy crosstalk", Cell Cycle, 10, pp.4032~4038 (2011)
39. Zhu L, "Activation of TFEBmediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury", Theranostics, 10, pp.5829~5844 (2020)
40. Wang J, "Role of autophagy in cisplatin resistance in ovarian cancer cells", J Biol Chem, 289, pp.17163~17173 (2014)

관련 논문AI추천